Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer. - Test2 - elhamkhani - TriplyDB

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

http://www.wikidata.org/entity/Q37553857

about

The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival.Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer.A critical review on HE4 performance in endometrial cancer: where are we now?Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset.Physiopathological factors affecting the diagnostic value of serum HE4-test for gynecologic malignancies.Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer.Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.Value of HE4 Combined with Cancer Antigen 125 in the Diagnosis of Endometrial Cancer.Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials.HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program.Serum endocan levels in endometrial and ovarian cancers.Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study.The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions.Discovery of biomarkers for endometrial cancer: current status and prospects.Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.

P2860

Q26992102-81FF678A-9F04-4FB9-9E98-9D0C2AF58E25 Q34062135-1FA02C15-687D-453C-AB83-389E854927AB Q35128002-E247B4A7-531B-4D33-83A1-BBA948163A27 Q35190572-B368023C-592C-49E3-9E8B-2B97E3E276E4 Q36790307-B133B03E-A07A-4A23-9FFE-CA0791317C14 Q37375504-8079DB3C-6995-4505-9A77-425506E97E0B Q37473123-302A161C-838F-4D7B-B5BE-04978F50FCF1 Q38143730-60476341-BC0E-4AE8-8CAF-5AA0DDB68253 Q38846968-28D44955-83D0-4ADE-8F98-A2876A4B5A0F Q38991579-159F111C-A4E2-40DA-99E6-8E08ABE5473B Q39014460-32A2E1A4-5A00-46B9-BAFD-E41D2ECBB44E Q39021988-4EB4ED5B-BA0E-4390-808F-8191F604CB2F Q40246622-B3E8C9B8-A622-4DCA-98FD-30C9E92D0F88 Q42659935-BED30B3E-1B71-4860-81EB-0DED61E370BC Q42942390-75562A97-7A16-4F62-A52D-01436855A159 Q43603831-B1BEE8C5-AAD9-461F-B1D7-339D0736F8B4 Q46748240-4B7B1828-44F2-4CD9-8C17-F9C97F677C51 Q47644020-789691DF-EBE3-456D-A46B-6993A0EE910C Q47797102-3C8027EB-AE98-442C-AD26-83DBE1696BB2 Q47972647-83E3E283-1FCA-47D2-BD36-585C6B2B449D Q47982714-DE17F65C-3132-4A1B-81A8-407EB31AB91C Q49199791-9904D99C-7A7B-4160-A9B3-E28E67BF14DC Q50594577-4C1C676F-CA1B-4318-A645-3D25BB220E55 Q51242071-D82FE35C-C67B-41D6-88F2-7BE3DE5BF8EA Q51341963-0BBCDF57-EBFC-41B8-9A9E-F1F21F52A6C8 Q53402383-21CBCA53-A2EA-4D4B-965F-B7540B05F9BE Q54993659-F6011953-AB14-49D1-8DCF-9E441775A625

P2860

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

http://www.wikidata.org/entity/Q37553857

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@en

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@nl

type

label

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@en

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@nl

prefLabel

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@en

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

@nl

P1433

Q37553857-7FD8C587-3FC2-4784-B586-4D82C0DF79E3

P1476

Q37553857-602E60A0-1AE8-4A05-88DF-807403C39D53

P2093

Q37553857-0BD2E2C9-5E5C-49A9-8030-BE7B0ABF8422

Q37553857-0C4768D8-3E78-4AF3-9630-465B57839AB5

Q37553857-237CD1BF-F024-40CA-90D9-E998C67BBC36

Q37553857-77D275FA-E6FA-46AA-B3BB-10A19E765653

Q37553857-A7F05C82-03BC-4767-9109-1FC3E7EE2B0D

Q37553857-B4BFCAF7-3578-42D6-A71B-BF2459B14BB0

Q37553857-C61CE987-40C1-4A9E-8474-51D3006E28A5

Q37553857-DB9D4279-6F30-462F-8339-83456F8A1F02

P2860

Q37553857-002EF0CD-E742-438B-9FB7-8F2919DBEBF4

Q37553857-025CF90C-C31F-42A4-914B-C497A0667788

Q37553857-07D34960-B7D8-40F0-BE6E-F1A0EEA551BF

Q37553857-10D3582E-6B1D-41BC-9094-1800E8CF8FCD

Q37553857-150A179D-D21C-4FEB-B9B5-D015168CAE79

Q37553857-155C5036-F5E3-4535-9F6D-5566D6FC266D

Q37553857-1BE3FEDC-32C4-4E37-8AA3-BE63BDB0F361

Q37553857-1D77B329-001A-481F-A923-CDAA64276286

Q37553857-4B295799-3555-44EF-81FC-CAF0490E7B75

Q37553857-4FF578E8-B7BF-420B-9BC2-54309821A41D

P304

Q37553857-73DE60FB-9F2B-4AEC-9DBC-0F5C918B1739

P31

Q37553857-9317082C-80E5-4FC1-8AA3-7A5BD1E54933

P356

Q37553857-3ABC77E5-CE43-4291-97A4-267EA73427E3

P407

Q37553857-851B54A1-152E-4C75-AD4B-FB7892A86352

P433

Q37553857-29AE3075-8446-4E52-A30B-BBF49F3E8396

P478

Q37553857-C6FD1CCE-79D3-4EFC-870C-48DD9323F853

P50

Q37553857-81706F53-1CA7-4A53-ADE4-42B428569F7F

Q37553857-B5EBC0EC-5EE0-4498-A66D-F7BC1AA2A296

P577

Q37553857-22E3678D-8E6C-42FA-92CB-53F3328AE3B7

P5875

Q37553857-A8A4909B-37A4-41EE-B66B-06D6AFD30016

P698

Q37553857-37803EEE-1EE2-4F0E-8392-FDAD6F9F465B

P932

Q37553857-CF672770-9D20-4984-8C01-6EEF1C4EF669

P356

J.YGYNO.2011.10.025

P1433

Gynecologic Oncology

P1476

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer

@en

P2093

Amy Weaver

http://www.w3.org/2001/XMLSchema#string

Cecelia Powless

http://www.w3.org/2001/XMLSchema#string

Eleftheria Kalogera

http://www.w3.org/2001/XMLSchema#string

Jinping Li

http://www.w3.org/2001/XMLSchema#string

Karl Podratz

http://www.w3.org/2001/XMLSchema#string

Nicole Urban

http://www.w3.org/2001/XMLSchema#string

Sean C Dowdy

http://www.w3.org/2001/XMLSchema#string

Shi-Wen Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung

A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors

Gene expression patterns in ovarian carcinomas

The evolution of a genetic locus encoding small serine proteinase inhibitors

Cancer statistics, 2010

Cloning and analysis of mRNAs expressed specifically in the human epididymis

SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other

Proteins with whey-acidic-protein motifs and cancer

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

P304

270-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2011.10.025

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Nathalie Scholler

P577

2011-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51756656

http://www.w3.org/2001/XMLSchema#string

P698

22037318

http://www.w3.org/2001/XMLSchema#string

P932

3913473

http://www.w3.org/2001/XMLSchema#string